An investigation for shareholders in bluebird bio Inc (NASDAQ:BLUE) shares over potential securities laws violations by bluebird bio was announced and NASDAQ:BLUE stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 12/09/2015 -- An investigation for shareholders of NASDAQ:BLUE shares over potential securities laws violations by bluebird bio was announced.
Investors who purchased shares of bluebird bio Inc (NASDAQ:BLUE), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.
The investigation by a law firm focuses on whether a series of statements by bluebird bio regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
bluebird bio Inc reported that its annual Total Revenue rose from $0.34 million in 2012 to $25.42 million in 2014. Shares of bluebird bio Inc (NASDAQ:BLUE) grew from $17.69 per share in May 2014 to as high as $197.30 per share on May 29, 2015.
On December 5, 2015, bluebird bio Inc announced that new data from the ongoing Northstar Study evaluating its LentiGlobin® BB305 product candidate in patients with beta-thalassemia major will be presented at the 57th American Society of Hematology Annual Meeting.
On December 6, 2015 bluebird bio Inc announced the presentation of new data from the ongoing HGB-205 and HGB-206 clinical studies evaluating its LentiGlobin BB305 product candidate in patients with beta-thalassemia major and severe sickle cell disease (SCD), at the 57th American Society of Hematology Annual Meeting.
In a separate announcement bluebird bio Inc announced also on December 6, 2015, that pre-clinical data from its anti-BCMA oncology program were presented by bluebird bio scientists at the 57thAmerican Society of Hematology Annual Meeting.
Since then NASDAQ:BLUE shares declined to as low as $51.72 per share on December 7, 2015.
Those who purchased shares of bluebird bio Inc (NASDAQ:BLUE) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com